See more : Newcrest Mining Limited (NCM.TO) Income Statement Analysis – Financial Results
Complete financial analysis of United-Guardian, Inc. (UG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of United-Guardian, Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Vertical Exploration Inc. (CVVRF) Income Statement Analysis – Financial Results
- Spectrum Brands Holdings, Inc. (SPB) Income Statement Analysis – Financial Results
- Altamin Limited (AZI.AX) Income Statement Analysis – Financial Results
- IKONICS Corporation (IKNX) Income Statement Analysis – Financial Results
- Thai Nakarin Hospital Public Company Limited (TNH.BK) Income Statement Analysis – Financial Results
United-Guardian, Inc. (UG)
About United-Guardian, Inc.
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.89M | 12.70M | 13.93M | 10.99M | 13.60M | 13.77M | 12.97M | 10.78M | 14.01M | 13.45M | 15.42M | 13.83M | 14.34M | 13.72M | 13.28M | 12.29M | 11.89M | 12.20M | 12.13M | 11.12M | 11.16M | 9.09M | 9.58M | 10.45M | 9.10M | 8.80M | 8.80M | 8.00M | 7.00M | 6.70M | 7.00M | 6.30M | 5.00M | 4.60M | 7.10M | 6.10M | 4.80M | 4.50M |
| Cost of Revenue | 5.48M | 6.00M | 5.75M | 4.87M | 5.66M | 5.67M | 5.30M | 4.88M | 5.20M | 5.32M | 5.61M | 5.22M | 5.65M | 5.25M | 5.32M | 5.41M | 4.85M | 5.64M | 5.69M | 5.07M | 5.06M | 4.90M | 4.65M | 4.76M | 4.60M | 4.40M | 5.00M | 4.90M | 4.20M | 4.20M | 4.10M | 3.60M | 3.00M | 4.40M | 6.70M | 4.40M | 3.40M | 2.80M |
| Gross Profit | 5.41M | 6.70M | 8.18M | 6.11M | 7.94M | 8.10M | 7.67M | 5.89M | 8.80M | 8.13M | 9.81M | 8.61M | 8.69M | 8.47M | 7.95M | 6.88M | 7.03M | 6.55M | 6.44M | 6.05M | 6.10M | 4.19M | 4.93M | 5.68M | 4.50M | 4.40M | 3.80M | 3.10M | 2.80M | 2.50M | 2.90M | 2.70M | 2.00M | 200.00K | 400.00K | 1.70M | 1.40M | 1.70M |
| Gross Profit Ratio | 49.66% | 52.78% | 58.74% | 55.65% | 58.40% | 58.84% | 59.12% | 54.69% | 62.86% | 60.46% | 63.61% | 62.25% | 60.59% | 61.74% | 59.90% | 55.98% | 59.17% | 53.74% | 53.10% | 54.40% | 54.64% | 46.14% | 51.44% | 54.41% | 49.45% | 50.00% | 43.18% | 38.75% | 40.00% | 37.31% | 41.43% | 42.86% | 40.00% | 4.35% | 5.63% | 27.87% | 29.17% | 37.78% |
| Research & Development | 463.99K | 490.77K | 478.64K | 451.21K | 397.39K | 399.52K | 646.08K | 651.83K | 648.21K | 730.41K | 717.00K | 693.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.79M | 1.85M | 1.86M | 2.64M | 2.50M | 2.51M | 2.55M | 3.42M | 2.61M | 2.70M | 2.60M | 2.83M | 2.59M | 2.59M | 2.46M | 2.30M | 2.34M | 2.26M | 2.10M | 2.20M | 2.00M | 2.00M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.08M | 2.17M | 2.04M | 2.03M | 2.15M | 2.12M | 1.79M | 1.85M | 1.86M | 2.64M | 2.50M | 2.51M | 2.55M | 3.42M | 2.61M | 2.70M | 2.60M | 2.83M | 2.59M | 2.59M | 2.46M | 2.30M | 2.34M | 2.26M | 2.10M | 2.20M | 2.00M | 2.00M | 1.90M | 1.80M | 1.80M | 1.80M | 1.30M | 100.00K | 0.00 | 1.70M | 1.80M | 1.50M |
| Other Expenses | 0.00 | 2.17M | 2.04M | 2.03M | 2.15M | 2.12M | 1.14M | 1.20M | 1.21M | 24.40K | 1.07M | 518.05K | 2.55M | 2.57M | 2.61M | 2.70M | 2.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 295.27K | 300.00K | 600.00K | 400.00K | 300.00K | 300.00K | 200.00K | 200.00K | 200.00K | 100.00K | 200.00K | 200.00K | 0.00 | 0.00 | 200.00K |
| Operating Expenses | 2.54M | 2.66M | 2.51M | 2.48M | 2.55M | 2.52M | 2.43M | 2.50M | 2.51M | 2.64M | 2.50M | 2.51M | 2.55M | 3.42M | 2.61M | 2.70M | 2.60M | 2.83M | 2.59M | 2.59M | 2.46M | 2.30M | 2.34M | 2.56M | 2.40M | 2.80M | 2.40M | 2.30M | 2.20M | 2.00M | 2.00M | 2.00M | 1.40M | 300.00K | 200.00K | 1.70M | 1.80M | 1.70M |
| Cost & Expenses | 8.02M | 8.66M | 8.26M | 7.35M | 8.20M | 8.19M | 7.73M | 7.39M | 7.71M | 7.96M | 8.12M | 7.73M | 8.20M | 8.67M | 7.93M | 8.11M | 7.45M | 8.47M | 8.28M | 7.66M | 7.52M | 7.20M | 6.99M | 7.32M | 7.00M | 7.20M | 7.40M | 7.20M | 6.40M | 6.20M | 6.10M | 5.60M | 4.40M | 4.70M | 6.90M | 6.10M | 5.20M | 4.50M |
| Interest Income | 306.65K | 236.70K | 233.86K | 226.25K | 203.33K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 325.02K | 332.65K | 455.79K | 395.26K | 492.44K | 575.03K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 1.62M | 0.00 | 0.00 | 0.00 | 227.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 56.00 | 798.00 | 0.00 | 0.00 | 0.00 | 0.00 | 38.00 | 536.00 | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 200.00K | 200.00K | 300.00K | 200.00K | 100.00K | 200.00K |
| Depreciation & Amortization | 105.68K | 135.40K | 145.98K | 165.26K | 175.81K | 191.94K | 200.68K | 187.04K | 173.48K | 181.19K | 189.73K | 254.44K | 255.58K | 229.78K | 178.69K | 200.80K | 197.80K | 195.37K | 205.81K | 209.79K | 203.81K | 256.99K | 275.30K | 295.27K | 300.00K | 600.00K | 400.00K | 300.00K | 300.00K | 200.00K | 200.00K | 200.00K | 100.00K | 200.00K | 200.00K | 0.00 | -100.00K | 200.00K |
| EBITDA | 2.97M | 4.17M | 5.81M | 3.80M | 5.57M | 5.77M | 5.44M | 3.58M | 6.47M | 5.67M | 6.16M | 6.35M | 6.39M | 5.29M | 5.52M | 4.38M | 4.64M | 3.86M | 4.06M | 3.67M | 3.85M | 2.15M | 2.87M | 3.42M | 2.40M | 2.10M | 1.80M | 1.10M | 900.00K | 700.00K | 1.10M | 900.00K | 700.00K | 300.00K | 100.00K | -200.00K | -400.00K | -400.00K |
| EBITDA Ratio | 27.27% | 38.17% | 39.17% | 28.32% | 35.01% | 41.35% | 37.94% | 30.34% | 43.80% | 38.86% | 39.96% | 38.12% | 41.76% | 38.53% | 41.59% | 35.72% | 38.92% | 28.75% | 31.48% | 31.03% | 32.95% | 21.52% | 27.43% | 30.50% | 25.27% | 23.86% | 20.45% | 12.50% | 12.86% | 10.45% | 15.71% | 12.70% | 12.00% | -4.35% | 5.63% | -3.28% | -10.42% | 11.11% |
| Operating Income | 2.86M | 4.04M | 5.67M | 3.64M | 5.40M | 5.58M | 5.24M | 3.39M | 6.29M | 5.49M | 7.30M | 6.10M | 6.14M | 5.06M | 5.34M | 4.18M | 4.44M | 3.72M | 3.85M | 3.46M | 3.64M | 1.89M | 2.59M | 3.13M | 2.10M | 1.60M | 1.40M | 800.00K | 600.00K | 500.00K | 900.00K | 700.00K | 600.00K | -100.00K | 200.00K | -200.00K | -400.00K | 300.00K |
| Operating Income Ratio | 26.30% | 31.79% | 40.68% | 33.10% | 39.68% | 40.52% | 40.37% | 31.45% | 44.93% | 40.83% | 47.36% | 44.11% | 42.79% | 36.86% | 40.25% | 34.02% | 37.33% | 30.54% | 31.74% | 31.13% | 32.64% | 20.81% | 27.06% | 29.95% | 23.08% | 18.18% | 15.91% | 10.00% | 8.57% | 7.46% | 12.86% | 11.11% | 12.00% | -2.17% | 2.82% | -3.28% | -8.33% | 6.67% |
| Total Other Income/Expenses | 387.75K | -809.55K | 210.84K | 524.83K | 634.41K | -113.99K | 315.17K | 306.51K | 331.83K | 264.00K | 1.33M | 828.21K | 736.09K | 455.79K | 395.68K | 484.68K | 583.93K | 470.11K | 237.46K | 220.99K | 169.34K | 192.10K | 239.08K | 237.61K | 100.00K | 0.00 | -100.00K | 0.00 | -100.00K | -300.00K | -200.00K | -100.00K | -100.00K | 100.00K | 100.00K | 200.00K | -100.00K | -100.00K |
| Income Before Tax | 3.25M | 3.23M | 5.88M | 4.16M | 6.03M | 5.47M | 5.55M | 3.70M | 6.63M | 5.75M | 8.63M | 6.93M | 6.87M | 5.51M | 5.74M | 4.67M | 5.02M | 4.14M | 4.09M | 3.68M | 3.81M | 2.08M | 2.83M | 3.37M | 2.20M | 1.60M | 1.30M | 800.00K | 500.00K | 200.00K | 700.00K | 600.00K | 500.00K | 0.00 | 300.00K | 0.00 | -500.00K | 500.00K |
| Income Before Tax Ratio | 29.86% | 25.42% | 42.20% | 37.88% | 44.34% | 39.70% | 42.80% | 34.30% | 47.30% | 42.79% | 55.99% | 50.10% | 47.92% | 40.18% | 43.23% | 37.97% | 42.25% | 33.92% | 33.70% | 33.11% | 34.16% | 22.92% | 29.55% | 32.22% | 24.18% | 18.18% | 14.77% | 10.00% | 7.14% | 2.99% | 10.00% | 9.52% | 10.00% | 0.00% | 4.23% | 0.00% | -10.42% | 11.11% |
| Income Tax Expense | 669.41K | 658.17K | 1.22M | 856.02K | 1.27M | 1.11M | 1.71M | 1.11M | 2.02M | 1.70M | 2.73M | 2.10M | 2.16M | 1.71M | 1.86M | 1.50M | 1.60M | 1.40M | 1.47M | 1.21M | 1.34M | 662.34K | 941.06K | 1.31M | 800.00K | 600.00K | 500.00K | 300.00K | 200.00K | 100.00K | 200.00K | 200.00K | 200.00K | 500.00K | 300.00K | -200.00K | -100.00K | 200.00K |
| Net Income | 2.58M | 2.57M | 4.66M | 3.30M | 4.76M | 4.35M | 3.84M | 2.58M | 4.61M | 4.05M | 5.90M | 4.83M | 4.72M | 3.80M | 3.88M | 3.16M | 3.54M | 2.74M | 2.62M | 2.48M | 2.47M | 1.42M | 1.89M | 2.05M | 1.40M | 1.00M | 800.00K | 500.00K | 300.00K | 100.00K | 500.00K | 600.00K | 300.00K | -600.00K | 0.00 | -200.00K | -400.00K | 100.00K |
| Net Income Ratio | 23.71% | 20.23% | 33.44% | 30.08% | 35.01% | 31.61% | 29.64% | 23.95% | 32.89% | 30.12% | 38.29% | 34.94% | 32.89% | 27.69% | 29.22% | 25.73% | 29.81% | 22.44% | 21.57% | 22.25% | 22.15% | 15.64% | 19.73% | 19.65% | 15.38% | 11.36% | 9.09% | 6.25% | 4.29% | 1.49% | 7.14% | 9.52% | 6.00% | -13.04% | 0.00% | -3.28% | -8.33% | 2.22% |
| EPS | 0.56 | 0.56 | 1.01 | 0.72 | 1.04 | 0.95 | 0.84 | 0.56 | 1.00 | 0.88 | 1.28 | 1.05 | 1.03 | 0.80 | 0.78 | 0.64 | 0.72 | 0.55 | 0.53 | 0.50 | 0.50 | 0.29 | 0.39 | 0.42 | 0.28 | 0.21 | 0.17 | 0.11 | 0.06 | 0.03 | 0.10 | 0.12 | 0.06 | -0.12 | 0.00 | -0.05 | -0.07 | 0.02 |
| EPS Diluted | 0.56 | 0.56 | 1.01 | 0.72 | 1.04 | 0.95 | 0.84 | 0.56 | 1.00 | 0.88 | 1.28 | 1.05 | 1.03 | 0.80 | 0.78 | 0.64 | 0.72 | 0.55 | 0.53 | 0.50 | 0.50 | 0.29 | 0.39 | 0.42 | 0.28 | 0.21 | 0.17 | 0.11 | 0.06 | 0.03 | 0.10 | 0.12 | 0.06 | -0.12 | 0.00 | -0.05 | -0.07 | 0.02 |
| Weighted Avg Shares Out | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.58M | 4.59M | 4.59M | 4.59M | 4.60M | 4.60M | 4.60M | 4.60M | 4.74M | 4.95M | 4.95M | 4.94M | 4.94M | 4.94M | 4.93M | 4.90M | 4.88M | 4.87M | 4.88M | 4.89M | 4.88M | 4.71M | 4.55M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 4.76M | 4.00M | 5.71M | 4.80M |
| Weighted Avg Shares Out (Dil) | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.58M | 4.59M | 4.59M | 4.59M | 4.60M | 4.60M | 4.60M | 4.60M | 4.74M | 4.95M | 4.95M | 4.95M | 4.94M | 4.94M | 4.94M | 4.91M | 4.89M | 4.89M | 4.91M | 4.91M | 4.90M | 4.71M | 4.55M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 4.76M | 4.00M | 5.71M | 4.80M |
Steep price declines in gold, silver amid China Covid worries
U.S. yields are hurting the gold price
After touching $2k, why did gold price tumble $70?
Gold price tanks as Powell is about to ‘overtighten', cause ‘panic in U.S. equities'
Here's what latest gold price pattern tells investors about the metal's next move
Sentiment in gold mixed so price could be headed anywhere as resistance holds at $2,000
More downside price action in gold, silver amid hawkish Fed
The gold price takes a dive with support levels now in focus
Gold price continues to consolidate as Fed's Powell reiterates hawkish stance; ECB's Lagarde remains patient
Gold price outlook 'healthy' as $1,900 level holds during next few quarters – S&P Global
Source: https://incomestatements.info
Category: Stock Reports